AstraZeneca shares fall 5% on disappointing lung cancer drug trial results

AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop in seven months, after the British pharmaceutical giant announced disappointing lung cancer drug trial results.

The Covid-19 vaccine maker was trading at the bottom of the FTSE 100 and dragged the wider healthcare sector lower after data published Monday showed that its experimental drug did not significantly improve overall survival results for patients.

Share were down 4.9% by 9:43 a.m. London time.

This is a breaking news story. Please check back for updates.

Source

World

Sweden’s Volvo Cars pops 10% on quarterly profit beat

July 17, 2025

Volvo vehicles seen outside a Volvo dealership in Edmonton, AB, Canada, on February 02, 2025. Nurphoto | Nurphoto | Getty Images Shares of Sweden-based automaker Volvo Cars rose more than 10% on Thursday as the company’s second-quarter operating profit beat analyst expectations despite a sharp year-on-year decline. Volvo Cars, which is owned by China’s Geely […]

World

CNBC’s Inside India newsletter: Musk’s India relationship moves beyond talk — but will it blossom?

July 17, 2025

Hello, this is Spriha Srivastava, CNBC International’s executive editor, writing from London. This week, I look into Elon Musk’s relationship with India, why it’s finally moving from talk to action, and what’s really at stake. This report is from this week’s CNBC’s “Inside India” newsletter. Like what you see? You can subscribe here. The big story […]

World

China’s premier urges tighter price oversight as deflation pressures squeeze economy

July 17, 2025

TOPSHOT – China’s Premier Li Qiang delivers his speech during the ASEAN – Gulf Cooperation Council (GCC) – China Economic Forum official dinner after the 46th Association of Southeast Asian Nations (ASEAN) Summit in Kuala Lumpur on May 27, 2025. Vincent Thian | Afp | Getty Images Chinese Premier Li Qiang has called for tighter […]